1

                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

                                                  Commission File Number 0-28666
                                                                         -------



(Check One):
[X] Form 10-K and Form 10-KSB    [ ] Form 11-K   [ ] Form 20-F   [ ] Form 10-QSB
[ ] Form N-SAR

         For period ended  April 30, 2001 .
                          ----------------

         Nothing in this Form shall be construed to imply that the Commission
has verified any information contained herein.

         If the  notification  relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:  N/A
                                                        -------


                                     PART I
                             REGISTRANT INFORMATION

Full name of registrant    American Bio Medica Corporation

Address of principal executive office (street and number)       122 Smith Road
                                                                --------------

City, state and zip code   Kinderhook, NY 12106
                           --------------------


                                     PART II
                             RULES 12b-25(b) AND (c)

         If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)

         (a)      The reasons described in reasonable detail in Part III of this
                  form could not be eliminated without unreasonable effort or
                  expense;

[X]      (b)      The subject annual report on Form 10-KSB will be filed on or
                  before the 15th calendar day following the prescribed due
                  date; and

         (c)      The accountant's statement or other exhibit required by Rule
                  12b-25(c) has been attached if applicable.

   2

                                    PART III
                                    NARRATIVE

         State below in reasonable detail the reasons why the Form 10-KSB could
not be filed within the prescribed time period. (Attach extra sheets if needed.)

         The registrant has devoted substantial time in negotiating a private
placement. Due to its limited resources and the complexities involved in the
private placement, it was unable to file the Form 10-KSB by the prescribed due
date without unreasonable time and effort. The private placement should be
completed by July 31, 2001 at which time the registrant could devote all of its
time to the Form 10-KSB. The registrant expects to file it Form 10-KSB on or
before August 13, 2001.


                                     PART IV
                                OTHER INFORMATION

(1)      Name and telephone number of person to contact in regard to this
         notification:

         Keith E. Palmer, Chief Financial Officer  (518)          758-8158
         -----------------------------------------------------------------------
         (Name)                                  (Area Code)  (Telephone Number)

(2)      Have all other periodic reports required under Section 13 or 15(d) of
         the Securities Exchange Act of 1934 or Section 30 of the Investment
         Company Act of 1940 during the preceding 12 months or for such shorter
         period that the registrant was required to file such report(s) been
         filed? If the answer is no, please identity report(s).
                                                             [X] Yes   No [ ]

(3)      Is it anticipated that any significant change in results of operations
         from the corresponding period for the last fiscal year will be
         reflected by the earnings statements to be included in the subject
         report or portion thereof?

                                                             [ ] Yes   No [X]



                                       2

   3


                                    SIGNATURE

                         AMERICAN BIO MEDICA CORPORATION
                         -------------------------------
                  (Name of Registrant as Specified in Charter)


Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.

Date:  July 30, 2001                        By:   /s/ Stan Cipkowski
                                                ---------------------------
                                                Stan Cipkowski, President